Cat.#: ACPP-1724
| Despition | FGF13 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1556 | Human SMARCA4 Protein (AC1556) | 5 µg | inquiry |
| ACPP-1110 | Recombinant Human ROR1 Protein (6×His Tag) (AC1110) | 50 µg | inquiry |
| ACPP-1699 | Human Human Prealbumin (Active) Protein (AC1699) | 1 mg | inquiry |
| ACPP-1457 | Rat NME2 Protein (AC1457) | 5 µg | inquiry |
| ACPP-1173 | Recombinant Human alpha Synuclein Protein (AC1173) | 50 µl | inquiry |
| ACPP-1358 | CRMP3 Blocking Peptide (AC1358) | 250 µg | inquiry |
| ACPP-1653 | Human CRYM Protein (AC1653) | 2 µg | inquiry |
| ACPP-1001 | Recombinant Human DEGA Protein (6×His Tag) (AC1001) | 50 µg | inquiry |
| ACPP-1447 | Human CANX Protein (AC1447) | 10 µg | inquiry |
| ACPP-1821 | Human NT 4 Protein (AC1821) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.